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hyperintensities were scored according to the modiﬁed Scheltens score.
Signiﬁcance level for the used tests is p= 0.05.
Results: The mean age was 68.8  3.4 years old. The distribution of
gender, smoking and dyslipidemia among the 4 groups was not signif-
icant. The hypertension duration, oﬃce and 24-h ABPM BP measure-
ments and MRI score varied signiﬁcantly between the 4 groups
(p < 0.0005). The hypertension duration and the average awake sys-
tolic blood pressure had the stronger impact on the MMSE class of
the patient (R2 = 0.87, p < 0.0005). Classifying the patients into con-
trolled and uncontrolled hypertensives, we had a higher percentage
of uncontrolled BP in every cognitive impairment class. Only 1 patient
with normal cognitive function had an uncontrolled hypertension.
MMSE score has a sensitivity and speciﬁcity of 94% and 83% respec-
tively in the prediction of uncontrolled hypertension.
Conclusion: We conclude that MMSE is a simple test to run in
clinic and can give an idea about the degree of structural damage
caused to the brain; and hence predict whether or not the patient’s
BP is well controlled. This would not replace the 24-hour ABPM
but may help guide the clinicians to request this 24-hour
monitoring.
http://dx.doi.org/10.1016/j.ehj.2013.12.038
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Background: Low-dose Warfarin (LDW) throughout pregnancy was
suggested to provide safe and eﬀective anticoagulation in pregnant
patients with mechanical heart valve prosthesis (MHVP). We aimed
to study its rate of failure in achieving target INR of those patients.
Methods: Group A: 100 pregnant patients with mitral (+aortic; 24%)
MHVP were randomized in a 3:1 ratio, to either receive LDW (<5 mg/
day) or phenindione (<100 mg/day) throughout pregnancy; respec-
tively. Group B: 100 females in the child-bearing period with mitral
(+aortic; 19%) MHVP were randomized similarly and followed same
dosage limits. Both groups targeted an INR of 2.5–3.5. Patients failing
to reach this target were shifted to the other oral anticoagulant (OA).
Aspirin (100 mg/day) was supplemented on the 2nd trimester / 4th fol-
low-up month (Group B).
Results: Primary outcome: 20 patients in Group A (26.7%; 16.7–
36.7%; P= 0.003) and 4 patients in Group B (5.3%; 0.23–10.37%;
P= 0.5) failed to achieve target INR; all being on LDW. Secondary
outcomes: Group A received larger doses of either OA (P < 0.0001)
achieved lower INR values (P < 0.0001) and had higher failure rates,
compared to Group B (relative risk: 5; 1.8–13.9); (P= 0.001). We
had no patient mortality or fetal embryopathy but 9 spontaneous
abortions and 2 stillbirths related to insigniﬁcantly higher OA doses
and lower INR achieved (P= 0.039).
Conclusions: LDW may be insuﬃcient to reach INR target, especially
in high-risk pregnant patients with MHVP. Phenindione can oﬀer an
eﬀective and probably safe alternative. NCT01758640.
http://dx.doi.org/10.1016/j.ehj.2013.12.039
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Background: Hemorrhagic complications have been strongly linked
with subsequent morbidity and mortality in patients with acute coro-
nary syndromes (ACS).
Objectives: To determine the incidence and predictors of major bleed-
ing and its impact on outcomes, including mortality, in patients with
ACSs.
Methods: Patients (n_ 200) with ACS, clinical data, management strat-
egies, complications and outcome were reported in case report form.
Factors associated with major bleeding were identiﬁed using logistic
regression analysis and impact of major bleeding on outcomes, includ-
ing mortality was reported.
Results: Bleeding occurred in 41 pts (20.5%), and was classiﬁed as nui-
sance (15 pts, 7.5%), minor (21pts, 10.5%) and major bleeding (5pts,
2.5%). Advanced age (p= 0.02), interventional coronary procedures
(p= 0.001), low BMI (p= 0.047), Clopidogrel loading > 300 mg
(p= 0.006) and renal insuﬃciency (p= 0.04) were independently
associated with a higher risk of major bleeding. Bleeding was indepen-
dently associated with an increased risk of hospital and 30 day inci-
dence of death, MI and stroke (p= 0.03). Patients with major
bleeding showed higher frequency of blood transfusion (p= 0.0001),
discontinuation of antithrombotics (p= 0.0001), mortality
(p= 0.0001), and MI (p= 0.02). Haemoglobin decrease at cut oﬀ
point of 3.4 gm predicted major complications with sensitivity 91%
and speciﬁcity 88% with AUC of 0.9 and (p= 0.0001).
Conclusions: Major bleeding is a powerful independent predictor of in-
hospital and 30 day mortality in patients with ACS. Advanced age,
renal insuﬃciency, high clopidogrel loading and invasive coronary
procedures are independent risk factors for major bleeding in ACS
patients.
http://dx.doi.org/10.1016/j.ehj.2013.12.040
Matrix carboxy glutamic acid protein serum level in type 2 diabetes
mellitus patients with coronary artery disease
Background: Poor glycemic control is a very strong independent pre-
dictor of vascular calciﬁcation which is a well known manifestation
of atherosclerosis and plays a signiﬁcant role in the development of
cardiovascular complications in systemic disease. Diﬀerent factors
for initiating vascular calciﬁcation are proposed, these include matrix
gamma carboxy glutamate protein (MGP), osteopontin and fetuin-
A. MGP is a vitamin K-dependent extracellular matrix protein that
binds to calcium ions and is involved in the prevention of vascular
calciﬁcation.
Aim: The present work aimed at evaluating serum level of matrix car-
boxy glutamic acid protein in type two diabetes mellitus male patients
with coronary artery disease.
Subjects and methods: The present study was conducted on eighty
male patients divided into four main groups. The control group
included 20 apparently healthy males, the ischemic group included
20 male patients suﬀered from ischemic heart disease, diabetic group
included 20 male patients suﬀered from type 2 diabetes mellitus and
the mixed group included 20 male patients suﬀered from both ische-
mic heart disease and type 2 diabetes mellitus. To all the studied sub-
jects the following was done: thorough history taking , physical
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